YARDLEY, Pa., Aug. 02, 2024 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced the Company will report financial results for the second quarter 2024 and corporate updates, before market open, on Thursday, August 8, 2024.
Optinose Announces Reporting Date for Second Quarter 2024 Financial Results
OPTINOSE INC
NASDAQ:OPTN (2/11/2025, 3:53:01 PM)
5.56
-0.14 (-2.46%)
OPTN Latest News and Analysis
a day ago - ChartmillMonday's pre-market session: top gainers and losersDiscover the top movers in Monday's pre-market session and stay informed about market dynamics.
